Palisade Bio Inc. (PALI): Price and Financial Metrics
PALI Price/Volume Stats
| Current price | $1.75 | 52-week high | $22.35 |
| Prev. close | $1.80 | 52-week low | $1.38 |
| Day low | $1.75 | Volume | 124,300 |
| Day high | $1.86 | Avg. volume | 670,552 |
| 50-day MA | $2.61 | Dividend yield | N/A |
| 200-day MA | $4.17 | Market Cap | 2.65M |
PALI Stock Price Chart Interactive Chart >
Palisade Bio Inc. (PALI) Company Bio
Palisade Bio is a biopharmaceutical company focused on developing therapeutics that protect the integrity of the intestinal barrier. The Company utilizes over three decades of research and established science that links the role of intestinal barrier biology and human disease to develop novel therapeutics that target and improve the integrity of the intestinal barrier. The Company’s lead program, LB1148, is a broad-spectrum serine protease inhibitor which acts to neutralize digestive enzymes, potentially reducing intestinal damage. In clinical studies, LB1148 has demonstrated positive results in reducing the incidence and severity of post-surgical abdominal adhesions and accelerating the time to return of postoperative bowel function. LB1148 is being investigated in a Phase 2 study to evaluate return of gastrointestinal function, post-operative ileus and intra-abdominal adhesions in subjects undergoing elective bowel resection. (copied from company website @ https://www.palisadebio.com/about-us/)
PALI Price Returns
| 1-mo | -28.28% |
| 3-mo | -53.46% |
| 6-mo | -62.12% |
| 1-year | -80.49% |
| 3-year | -99.86% |
| 5-year | -100.00% |
| YTD | -80.23% |
| 2023 | -88.65% |
| 2022 | -92.00% |
| 2021 | -75.38% |
| 2020 | -99.70% |
| 2019 | -99.20% |
Loading social stream, please wait...